Citation Impact

Citing Papers

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial
1997
Human Hypertension Caused by Mutations in WNK Kinases
2001 StandoutScience
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
2007 Standout
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies
1991
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
β-Carotene and cancer prevention: the Basel Study
1991
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1996
Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
2004
Electrocardiographic identification of left ventricular hypertrophy: Test performance in relation to definition of hypertrophy and presence of obesity
1996
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
1997 Standout
Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
1993 Standout
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
2005 Standout
Molecular Mechanisms of Human Hypertension
2001 Standout
Changing patterns of mortality across Europe in patients infected with HIV-1
1998
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Grade 4 Events Are as Important as AIDS Events in the Era of HAART
2003
Improved electrocardiographic diagnosis of left ventricular hypertrophy
1994
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
1996 Standout
The importance of selenium to human health
2000 Standout
Treatment for Adult HIV Infection
2006
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Obesity and Cardiovascular Disease
2009 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Blood Pressure and End-Stage Renal Disease in Men
1996 Standout
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
1997
Serum Beta-Carotene in Persons with Cancer and Their Immediate Families
1991
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
Treatment for Adult HIV Infection
2004
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Trends in the Prevalence of Hypertension, Antihypertensive Therapy, and Left Ventricular Hypertrophy from 1950 to 1989
1999
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Immunological recovery and antiretroviral therapy in HIV-1 infection
2006
Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
2001 Standout
Is Low Selenium Status a Risk Factor for Lung Cancer?
1998
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Biology of cutaneous squamous cell carcinoma
1992
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data
1993
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
1992 Standout
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
1992
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols
1991
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
2008
Challenges, successes and patterns of enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Does beta-carotene explain why reduced cancer risk is associated with vegetable and fruit intake?
1992
Antioxidant nutrients and disease prevention: an overview
1991
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
A Clinical Trial of Beta Carotene to Prevent Basal-Cell and Squamous-Cell Cancers of the Skin
1990
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.
1993
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout

Works of Gary Collins being referenced

Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter
1996
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial
1989
Relationship between carotenoids and cancer. The multiple risk factor intervention trial (MRFIT) study
1989
Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus
2003
Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
2009
Pulmonary function in an international sample of HIV‐positive, treatment‐naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
2015
Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
2015
Rankless by CCL
2026